Avsola 100 MG Injection

RxCUI
2266530
RxNorm name
Avsola 100 MG Injection
Display name
Avsola 100 MG Injection
Full name
Avsola 100 MG Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761086Avsolainfliximab-axxq351(k) BiosimilarRx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AVSOLAINFLIXIMAB-AXXQAmgen, Incde34bcb7-b524-45c8-9181-61c6f48d540e2026-07-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2266530

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
de34bcb7-b524-45c8-9181-61c6f48d540eAVSOLA 100 MG Injection [PSN] · infliximab-axxq 100 MG Injection [Avsola] [SBD] · Avsola 100 MG Injection [SY]318These highlights do not include all the information needed to use AVSOLA ® safely and effectively. See full prescribing information for AVSOLA. AVSOLA (infliximab-axxq) for injection, for intravenous use Initial U.S. Approval: 2019 AVSOLA (infliximab-axxq) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betwe20250908